Our success in addressing these challenges depends on our ability to properly interpret the large-scale, high-dimensional data sets that are generated by modern technologies, since it is becoming increasingly clear that a comprehensive analysis of biological systems requires the integration of all fingerprints of cellular function: genome sequence, maps of gene expression, protein expression, metabolic output, and in vivo enzymatic expression (activity). This need for integration is especially clear in the case of complex, multifactorial diseases, such as cancer.
At the same time the Virtual Physiological Human (VPH) framework aims to define methods and technologies that once fully established will enable the investigation of the human body as a whole, eventually leading to a better healthcare system that offers personalized care solutions, more holistic approach to medicine and a preventative approach to the treatment of disease. Although consensus exists about what the fundamental tools are (integration of highthroughput data from several biologic scales, high-definition imaging, and computational modeling), no such consensus exists as to what are the most promising scientific approaches in responding to these challenges.
A growing awareness is found that, despite significant technological advances in various domains of relevance, fundamental obstacles separate systems biology from clinical applications. Bridging these gaps will require a focused and concerted effort in addressing various questions, such as:
Furthermore, because of the necessary multiscale nature of the models bridging embedded levels of organization from molecules, organelles, cells, tissues, organs, and all the way to individuals, environmental factors, populations, and ecosystems, systems medicine aims to discover and select the key factors at each level and integrate them into models of translational relevance, which include measurable readouts and clinical predictions.
The Special Session will build on experiences as well as technological and scientific developments stemming from some flagship projects funded by the EU under the FP7 framework programme aiming to bring together researches working in the fields of infrastructures and technologies for integrative biomedical research, ICT for predictive and translational medicine and the VPH at large.
In addition the Special Session invites original research work in all aspects of Cancer Informatics with a focus on revealing progress, and challenges in some of core domains that support the vision of predictive and personalised medicine in the domain of cancer.
The Special session will draw upon experiences form some flagship EU funded projects such as:
Paper Submission Deadline: July 15, 2012
Paper Notification: August 15, 2012
Camera Ready Paper: September 8, 2012
For further information and registration, please visit:
About IEEE International Conference on BioInformatics and BioEngineering
The annual IEEE International Conference on Bioinformatics and Bioengineering cover complementary disciplines that hold great promise for the advancement of research and development in complex medical and biological systems, agriculture, environment, public health, drug design, and so on. Research and development in these two areas are impacting the science and technology of fields such as medicine, food production, forensics, etc. by advancing fundamental concepts in molecular biology and in medicine, by helping us understand living organisms at multiple levels, by developing innovative implants and bio-prosthetics, and by improving tools and techniques for the detection, prevention and treatment of 1diseases. The BIBE series provides a common platform for the cross fertilization of ideas, and to help shape knowledge and scientific achievements by bridging these two very important and complementary disciplines into an interactive and attractive forum. Keeping this objective in mind, BIBE solicits original contributions in the following non exclusive lists of areas.